4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000013
CEO bought 17,000 shares at an average $0.02 ($389)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-15 | Purchase : show line 1 in the form | +4,000 | $0.02 | $90 | 21,540,123 | D |
| 2019-02-15 | Purchase : show line 2 in the form | +1,000 | $0.02 | $23 | 21,541,123 | D |
| 2019-02-15 | Purchase : show line 3 in the form | +2,000 | $0.02 | $46 | 21,543,123 | D |
| 2019-02-15 | Purchase : show line 4 in the form | +10,000 | $0.02 | $230 | 21,553,123 | D |
| Open-market purchases · 17,000 sh · avg $0.02 · $389 | ||||||
Loading xslF345X03/primary_doc.xml…